Early supernormal retinal oxygenation response in patients with diabetes

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 4, 2006, Pages 1612-1619

  Trick, Gary L ^a,b   Edwards, Paul ^a   Desai, Uday ^a   Berkowitz, Bruce A ^b,c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; HYPEROXIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BREATHING; OXYGENATION; PRIORITY JOURNAL; TREATMENT RESPONSE; METABOLISM; MIDDLE AGED; OXIMETRY; PERIMETRY; PRESSURE; RETINA;

OXYGEN;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPEROXIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIMETRY; OXYGEN; PARTIAL PRESSURE; PERIMETRY; RETINA;

EID: 33646002681     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0833     Document Type: Article

References (50)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003. Revised ed. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2004.
2. Public health focus: prevention of blindness associated with diabetic retinopathy. MMWR Morb Mortal Wkly Rep. 1993;42:191-195.
3. Klein R, Klein BE, Moss SE. The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabetes Metab Rev. 1989;5:559-570.
4. Fong DS, Aiello L, Gardner TW, et al., for the American Diabetes Association. Diabetic retinopathy. Diabetes Care. 2003;26:S99-S102.
5. Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003;136:122-135.
6. Trick GL, Berkowitz BA. Retinal oxygenation response and retinopathy. Prog Retin Eye Res. 2005;24:259-274.
7. Berkowitz BA, Penn JS. Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1998;39:840-845.
8. Berkowitz BA, Zhang W. Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP. Invest Ophthalmol Vis Sci. 2000;41:1925-1931.
9. Berkowitz BA, Berlin ES, Zhang W. Variable supplemental oxygen during recovery does not reduce retinal neovascular severity in experimental ROP. Curr Eye Res. 2001;22:401-404.
10. Zhang W, Ito Y, Berlin E, Roberts R, Berkowitz BA. Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2003;44: 3119-3123.
11. 2 for retinal neovascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2003;44:3551-3555.
12. Berkowitz BA, Wilson CA. Quantitative mapping of ocular oxygenation using magnetic resonance imaging. Magn Reson Med. 1995;33:579-581.
13. 2 mapping. Invest Ophthalmol Vis Sci. 1996;37:2089-2098.
14. Berkowitz BA, Kowluru RA, Frank RN, Kern TS, Hohman TC, Prakash M. Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2100-2105.
15. Ito Y, Berkowitz BA. MR studies of retinal oxygenation. Vision Res. 2001;41:1307-1311.
16. Berkowitz BA, Ito Y, Kern TS, McDonald C, Hawkins R. Correction of early subnormal superior hemiretinal DeltaPO predicts therapeutic efficacy in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci. 2001;42:2964-2969.
17. Roberts R, Zhang W, Ito Y, Berkowitz BA. Spatial pattern and temporal evolution of retinal oxygenation response in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2003;44:5315-5320.
18. Berkowitz BA, Luan H, Gupta RR, et al. Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase. Diabetes. 2004;53:173-178.
19. Luan H, Leitges M, Gupta RR, et al. Effect of PKCbeta on retinal oxygenation response in experimental diabetes. Invest Ophthalmol Vis Sci. 2004;45:937-942.
20. Kohner EM, Patel V, Rassam SM. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes. 1995;44:603-607.
21. Berkowitz BA, McDonald C, Ito Y, Tofts PS, Latif Z, Gross J. Measuring the human retinal oxygenation response to a hyperoxic challenge using MRI: eliminating blinking artifacts and demonstrating proof of concept. Magn Reson Med. 2001;46:412-416.
22. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98:786-806.
23. Satterfield D, Lyons A. Development of a consensus publication by the Centers for Disease Control (CDC): the prevention and treatment of complications of diabetes - a guide for primary care practitioners. Diabetes Educ. 1992;18:473-475.
24. Javitt JC, Canner JK, Frank RG, Steinwachs DM, Sommer A. Detecting and treating retinopathy in patients with type I diabetes mellitus: a health policy model. Ophthalmology. 1990;97:483-494.
25. Trick GL, Liggett J, Levy J, et al. Dynamic contrast enhanced MRI in patients with diabetic macular edema. Exp Eye Res. 2005;81: 97-102.
26. Embleton SJ, Hosking SL, Roff Hilton EJ, Cunliffe IA. Effect of senescence on ocular blood flow in the retina, neuroretinal rim and lamina cribrosa, using scanning laser Doppler flowmetry. Eye. 2002;16:156-162.
27. Groh MJ, Michelson G, Langhans MJ, Harazny J. Influence of age on retinal and optic nerve head blood circulation. Ophthalmology. 1996;103:529-534.
28. Grunwald JE, Piltz J, Patel N, Bose S, Riva CE. Effect of aging on retinal macular microcirculation: a blue field simulation study. Invest Ophthalmol Vis Sci. 1993;34:3609-3613.
29. Lam AK, Chan ST, Chan H, Chan B. The effect of age on ocular blood supply determined by pulsatile ocular blood flow and color Doppler ultrasonography. Optom Vis Sci. 2003;80:305-311.
30. Dallinger S, Findl O, Strenn K, Eichler HG, Wolzt M, Schmetterer L. Age dependence of choroidal blood flow. J Am Geriatr Soc. 1998;46:484-487.
31. Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol. 1998;116:150-154.
32. Ravalico G, Toffoli G, Pastori G, Croce M, Calderini S. Age-related ocular blood flow changes. Invest Ophthalmol Vis Sci. 1996;37: 2645-2650.
33. Ibrahim YW, Bots ML, Mulder PG, Grobbee DE, Hofman A, de Jong PT. Number of perifoveal vessels in aging, hypertension, and atherosclerosis: the Rotterdam Study. Invest Ophthalmol Vis Sci. 1998;39:1049-1053.
34. Stanton AV, Wasan B, Cerutti A, et al. Vascular network changes in the retina with age and hypertension. J Hypertens. 1995;13:1724-1728.
35. Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD. Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology. 2004;111: 1183-1190.
36. Rassam SM, Patel V, Chen HC, Kohner EM. Regional retinal blood flow and vascular autoregulation. Eye. 1996;10:331-337.
37. Blum M, Bachmann K, Wintzer D, Riemer T, Vilser W, Strobel J. Noninvasive measurement of the Bayliss effect in retinal autoregulation. Graefes Arch Clin Exp Ophthalmol. 1999;237:296-300.
38. Blum M, Scherf C, Bachmann K, Strobel J. Age-related contractility of retinal arterioles during pure oxygen breathing [in German]. Ophthalmologe. 2001;98:265-268.
39. Chung HS, Harris A, Halter PJ, et al. Regional differences in retinal vascular reactivity. Invest Ophthalmol Vis Sci. 1999;40:2448-2453.
40. Jean-Louis S, Lovasik JV, Kergoat H. Systemic hyperoxia and retinal vasomotor responses. Invest Ophthalmol Vis Sci. 2005;46:1714-1720.
41. Kurtenbach A, Flogel W, Erb C. Anomaloscope matches in patients with diabetes mellitus. Graefes Arch Clin Exp Ophthalmol. 2002; 240:79-84.
42. Dean FM, Arden GB, Dornhorst A. Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects. Br J Ophthalmol. 1997;81:27-30.
43. Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology. 1988;95: 693-698.
44. Verrotti A, Lobefalo L, Petitti MT, et al. Relationship between contrast sensitivity and metabolic control in diabetics with and without retinopathy. Ann Med. 1998;30:369-374.
45. Han Y, Adams AJ, Bearse MA Jr, Schneck ME. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol. 2004;122:1809-1815.
46. Falsini B, Porciatti V, Scalia G, et al. Steady-state pattern electroretinogram in insulin-dependent diabetics with no or minimal retinopathy. Doc Ophthalmol. 1989;73:193-200.
47. Trick GL, Burde RM, Gordon MO, Kilo C, Santiago JV. Retinocortical conduction time in diabetics with abnormal pattern reversal electroretinograms and visual evoked potentials. Doc Ophthalmol. 1988;70:19 -28.
48. Brown JC, Kylstra JA, Mah ML. Entoptic perimetry screening for central diabetic scotomas and macular edema. Ophthalmol. 2000; 107:755-759.
49. Pahor D. Automated static perimetry as a screening method for evaluation of retinal perfusion in diabetic retinopathy. Int Ophthalmol. 1997-98;21:305-309.
50. Trick GL, Trick LR, Kilo C. Visual field defects in patients with insulin-dependent and noninsulin-dependent diabetes. Ophthalmology. 1990;97:475-482.